Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Pediatr Res. 2022 Mar 23;92(6):1671–1680. doi: 10.1038/s41390-022-02009-8

Figure 1.

Figure 1.

Classification scheme of patients with suspected SDS in NCI IBMFS cohort. Genetic testing methods included whole exome sequencing, targeted long-read PacBio sequencing of SBDS, EFL1, DNAJC21, and SRP54, or low-pass long-read whole genome sequencing.

aSDS-like participants did not have available samples for sequencing and/or external negative genetic testing results.